Skip to main content
Article thumbnail
Location of Repository

Two Modes of Transcriptional Activation at Native Promoters by NF-κB p65

By Dominic van Essen, Bettina Engist, Gioacchino Natoli and Simona Saccani


The NF-κB family of transcription factors is crucial for the expression of multiple genes involved in cell survival, proliferation, differentiation, and inflammation. The molecular basis by which NF-κB activates endogenous promoters is largely unknown, but it seems likely that it should include the means to tailor transcriptional output to match the wide functional range of its target genes. To dissect NF-κB–driven transcription at native promoters, we disrupted the interaction between NF-κB p65 and the Mediator complex. We found that expression of many endogenous NF-κB target genes depends on direct contact between p65 and Mediator, and that this occurs through the Trap-80 subunit and the TA1 and TA2 regions of p65. Unexpectedly, however, a subset of p65-dependent genes are transcribed normally even when the interaction of p65 with Mediator is abolished. Moreover, a mutant form of p65 lacking all transcription activation domains previously identified in vitro can still activate such promoters in vivo. We found that without p65, native NF-κB target promoters cannot be bound by secondary transcription factors. Artificial recruitment of a secondary transcription factor was able to restore transcription of an otherwise NF-κB–dependent target gene in the absence of p65, showing that the control of promoter occupancy constitutes a second, independent mode of transcriptional activation by p65. This mode enables a subset of promoters to utilize a wide choice of transcription factors, with the potential to regulate their expression accordingly, whilst remaining dependent for their activation on NF-κB

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1999). A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death.
    2. (2001). A higher-order background model improves the detection of promoter regulatory elements by Gibbs sampling.
    3. (2005). A highresolution map of active promoters in the human genome.
    4. (2003). A novel docking site on Mediator is critical for activation by VP16 in mammalian cells.
    5. (2003). A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression.
    6. (2004). A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology.
    7. (1994). An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation.
    8. (1994). Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators.
    9. (2006). Circuitry of nuclear factor kappaB signaling.
    10. (2003). Communication between NF-kappa B and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene.
    11. (1999). Composite co-activator ARC mediates chromatin-directed transcriptional activation.
    12. (2004). ConSite: web-based prediction of regulatory elements using cross-species comparison.
    13. (1998). Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA.
    14. (2004). Degradation of promoterbound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.
    15. (1998). Dissecting the regulatory circuitry of a eukaryotic genome.
    16. (2000). Distinct classes of yeast promoters revealed by differential TAF recruitment.
    17. (2000). Drosophila homologs of transcriptional mediator complex subunits are required for adult cell and segment identity specification.
    18. (2002). Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes.
    19. (2005). Dynamic regulation of pol II transcription by the mammalian Mediator complex.
    20. (2002). Evidence for a mediator of RNA polymerase II transcriptional regulation conserved from yeast to man.
    21. (1995). General requirement for RNA polymerase II holoenzymes in vivo.
    22. (2003). Genetic analysis of NF-kappaB/ Reltranscriptionfactorsdefinesfunctionalspecificities.EmboJ22:5530–5539.
    23. (2006). Genome-wide location of the coactivator mediator: Binding without activation and transient Cdk8 interaction on DNA.
    24. (2006). Head module control of mediator interactions.
    25. (2003). Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression.
    26. (2002). Human CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound conformation.
    27. (1995). Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B.
    28. (2005). Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time.
    29. (2003). Mediator and p300/CBP-steroid receptor coactivator complexes have distinct roles, but function synergistically, during estrogen receptor alpha-dependent transcription with chromatin templates.
    30. Mediator are coactivators of lipopolysaccharide- and heat-shock-induced transcriptional activators.
    31. (2003). Modulation of NF-kappaB activity by exchange of dimers.
    32. (2001). Novel critical role of a human Mediator complex for basal RNA polymerase II transcription.
    33. (2001). Positive and negative TAF(II) functions that suggest a dynamic TFIID structure and elicit synergy with traps in activator-induced transcription.
    34. (1994). Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250.
    35. (2006). Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors.
    36. RanishJA,YudkovskyN,HahnS(1999)Intermediatesinformationandactivity oftheRNApolymeraseIIpreinitiationcomplex:holoenzymerecruitmentand a postrecruitment role for the TATA box and TFIIB.
    37. (2008). Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms.
    38. (2002). Requirement of TRAP/mediator for both activator-independent and activator-dependent transcription in conjunction with TFIID-associated TAF(II)s.
    39. (2006). Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response.
    40. (2000). Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor.
    41. (2002). Structure, function, and activator-induced conformations of the CRSP coactivator.
    42. (2000). TAF-Containing and TAFindependent forms of transcriptionally active TBP in vivo.
    43. (1992). The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
    44. (2006). The classical srb4– 138 mutant allele causes dissociation of yeast Mediator.
    45. (1996). The general transcription factors of RNA polymerase II.
    46. (1991). The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
    47. (1999). The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1.
    48. (2000). The USA-derived transcriptional coactivator PC2 is a submodule of TRAP/SMCC and acts synergistically with other PCs.
    49. (1997). Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation.
    50. (2001). Two waves of nuclear factor kappaB recruitment to target promoters.
    51. (1995). Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome.
    52. (2002). Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation.
    53. (1997). Yeast TAF(II)145 required for transcription of G1/S cyclin genes and regulated by the cellular growth state.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.